As of August 28, 2026, CytoMed Therapeutics Limited (GDTC) has a DilutionWatch DilutionScore of 46/100, rated MEDIUM dilution risk. CytoMed Therapeutics Limited has a market capitalization of $13.84M, 11.83M shares outstanding, 3 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
⛅
Watch
Minor dilution signals detected
model est. 15%
🔄 Reverse Split
model est. 30%
• 50-day avg $1.02 approaching $1 threshold
Market Data
Market Cap$13.84M
Shares Outstanding11.83M
Float1.84M
Cash$1.64M
Debt$378.1K
Short InterestN/A
Institutional Holdings
QoQ: ↓ 69.2% shares (2026Q1 vs prior)
3 institutional holders · 16.3K shares
#1
XTX Topco Ltd
10.1K shares
#2
UBS Group AG
6.2K shares
#3
OSAIC HOLDINGS, INC.
21 shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest5.7K
Days to Cover1.0
% of Float0.3%
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track GDTC Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GDTC — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for GDTC
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.